R. Soffredini

Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis C

Maria Grazia Rumi, Alessio Aghemo, Gian Maria Prati et al. · Gastroenterology · 2009 · 199 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen–negative patients with chronic hepatitis B

Pietro Lampertico, Mauro Viganò, Cristina Cheroni et al. · Hepatology · 2012 · 157 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Genetic variation in the interleukin - 28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection

Francesco Marabita, Alessio Aghemo, Stella De Nicola et al. · Hepatology · 2011 · 124 citations · Full text

Medicine, Genetics, Infectious Diseases +17

Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection

Elisabetta Degasperi, Roberta D’Ambrosio, Massimo Iavarone et al. · Clinical Gastroenterology and Hepatology · 2018 · 114 citations

Medicine, Infectious Diseases, Pharmacotherapy +17

A multicenter randomized controlled trial of recombinant interferon-α2b in patients with acute transfusion-associated hepatitis C

Pietro Lampertico, Maria Grazia Rumi, R. Romeo et al. · Hepatology · 1994 · 104 citations · Full text

Pharmacy, Infectious Diseases, Internal Medicine +16